Natixis Edwards Lifesciences Corp Transaction History

Natixis

$16 Billion
Q4 2024

A detailed history of Natixis transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Natixis holds 246,211 shares of EW stock, worth $17.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

246,211

Previous 133,574 84.33%

Holding current value

$17.6 Million

Previous $8.81 Million 106.8%

% of portfolio

0.11%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$64.54 - $75.92 $7.27 Million - $8.55 Million	112,637 Added 84.33%	246,211 $18.2 Million
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $15.7 Million - $24.6 Million	-262,631 Reduced 66.29%	133,574 $8.81 Million
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $24.8 Million - $27.7 Million	293,904 Added 287.29%	396,205 $36.6 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $7.03 Million - $9.26 Million	-96,945 Reduced 48.66%	102,301 $9.78 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $22.1 Million - $27.9 Million	-358,814 Reduced 64.3%	199,246 $15.2 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $19.1 Million - $25.7 Million	275,029 Added 97.17%	558,060 $38.7 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $18.1 Million - $21 Million	222,318 Added 366.18%	283,031 $26.7 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $7.65 Million - $8.7 Million	-102,984 Reduced 62.91%	60,713 $5.02 Million
Q4 2022 Feb 24, 2023	BUY	$68.3 - $87.44 $3.26 Million - $4.18 Million	47,764 Added 41.2%	163,697 $12.2 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $2.78 Million - $3.55 Million	-40,643 Reduced 25.96%	115,933 $8.65 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $8.74 Million - $11.4 Million	106,122 Added 210.33%	156,576 $13.1 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $3.65 Million - $5.41 Million	-42,180 Reduced 45.53%	50,454 $4.8 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $7.38 Million - $9.29 Million	72,397 Added 357.75%	92,634 $10.9 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $1.03 Million - $1.27 Million	-9,681 Reduced 32.36%	20,237 $2.62 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $1.06 Million - $1.26 Million	-10,277 Reduced 25.57%	29,918 $3.39 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $6.35 Million - $7.93 Million	-75,721 Reduced 65.32%	40,195 $4.16 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $642,894 - $740,864	-8,171 Reduced 6.58%	115,916 $9.7 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $8.9 Million - $11.3 Million	124,087 New	124,087 $11.3 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $1.5 Million - $1.96 Million	-22,377 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$57.54 - $76.95 $1.07 Million - $1.44 Million	-18,654 Reduced 45.46%	22,377 $1.55 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $1.25 Million - $1.93 Million	23,849 Added 138.8%	41,031 $7.74 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $4.28 Million - $4.9 Million	-59,716 Reduced 77.66%	17,182 $3.99 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $4.73 Million - $5.8 Million	76,898 New	76,898 $16.9 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $1.56 Million - $1.99 Million	-34,235 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $136,306 - $164,724	-3,211 Reduced 8.58%	34,235 $4.98 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $808,250 - $1.03 Million	21,733 Added 138.31%	37,446 $5.22 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $587,641 - $685,031	-17,391 Reduced 52.53%	15,713 $1.77 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $1.2 Million - $1.29 Million	33,104	33,104 $3.62 Million

Others Institutions Holding EW

# of Institutions

1,380

Shares Held

485M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account